Mouse galanin receptor galr2 and nucleotides encoding same
CA 2275538 A1 · Owner: Board Of Regents, The University Of Texas System · Inventors: Tan, Carina P.; Kolakowski, Lee F. Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A new galanin receptor, GALR2, is described. Also provided are nucleic acids encoding same and various assays to identify ligands particular to said receptor. Ligands so identified are useful for the treatment of obesity treatment of pain, and treatment of cognitive disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 18, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 18, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 18, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.